Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
January 28 2022 - 06:10AM
Edgar (US Regulatory)

The following is a summary of the terms of the notes offered by the
preliminary pricing supplement hyperlinked below. Summary of Terms
Issuer: JPMorgan Chase Financial Company LLC Guarantor: JPMorgan
Chase & Co. Minimum Denomination: $1,000 Indices: EURO STOXX 50
® Index and STOXX ® Europe 600 Index Pricing Date: February 18,
2022 Observation Date: February 18, 2027 Maturity Date: February
23, 2027 Upside Leverage Factor: At least 2.72* Barrier Amount:
With respect to each Index, 70.00 % of its Initial Value Payment At
Maturity: If the Final Value of each Index is greater than its
Initial Value, your payment at maturity per $1,000 principal amount
note will be calculated as follows: $1,000 + ($1,000 î Lesser
Performing Index Return î Upside Leverage Factor) If the Final
Value of either Index is equal to or less than its Initial Value
but the Final Value of each Index is greater than or equal to its
Barrier Amount, you will receive the principal amount of your notes
at maturity. If the Final Value of either Index is less than its
Barrier Amount, your payment at maturity per $1,000 principal
amount note will be calculated as follows: $1,000 + ($ 1,000 î
Lesser Performing Index Return) If the Final Value of either Index
is less than its Barrier Amount, you will lose more than 30.00 % of
your principal amount at maturity and could lose all of your
principal amount at maturity. CUSIP: 48133C3J9 Preliminary Pricing
Supplement: http://sp.jpmorgan.com/document/cusip/ 48133C3J9
/doctype/Product_Termsheet/document.pdf Estimated Value: The
estimated value of the notes, when the terms of the notes are set,
will not be less than $920.00 per $1,000 principal amount note. For
information about the estimated value of the notes, which likely
will be lower than the price you paid for the notes, please see the
hyperlink above . Any payment on the notes is subject to the credit
risk of JPMorgan Chase Financial Company LLC, as issuer of the
notes, and the credit risk of JPMorgan Chase & Co., as
guarantor of the notes . * The actual Upside Leverage Factor will
be provided in the pricing supplement and will not be less than
2.72. **Reflects Upside Leverage Factor equal to the minimum Upside
Leverage Factor set forth herein, for illustrative purposes. The
“total return” as used above is the number, expressed as a
percentage, that results from comparing the payment at maturity pe
r $1,000 principal amount note to $1,000. The hypothetical returns
shown above apply only at maturity. These hypotheticals do not
reflect fees or expenses that would be associated with any sale in
the secondary market. If these fees and expenses were included, the
hypothetical returns shown above would likely be lower. J.P. Morgan
Structured Investments | 1 800 576 3529 |
jpm_structured_investments@jpmorgan.com Final Value of Lesser
Performing Index Lesser Performing Index Return Total Return on the
Notes 165.00 65.00% 176.80% 150.00 50.00% 136.00% 140.00 40.00%
108.80% 130.00 30.00% 81.60% 120.00 20.00% 54.40% 110.00 10.00%
27.20% 105.00 5.00% 13.60% 100.00 0.00% 0.00% 90.00 - 10.00% 0.00%
80.00 - 20.00% 0.00% 70.00 - 30.00% 0.00% 69.99 - 30.01% - 30.01%
60.00 - 40.00% - 40.00% 40.00 - 60.00% - 60.00% 20.00 - 80.00% -
80.00% 0.00 - 100.00% - 100.00% 5yr SX5E / SXXP Uncapped
Accelerated Barrier Notes North America Structured Investments
Hypothetical Total Returns**

J.P. Morgan Structured Investments | 1 800 576 3529 |
jpm_structured_investments@jpmorgan.com Selected Risks • Your
investment in the notes may result in a loss. The notes do not
guarantee any return of principal. • Any payment on the notes is
subject to the credit risks of JPMorgan Chase Financial Company LLC
and JPMorgan Chase & Co. Therefore the value of the notes prior
to maturity will be subject to changes in the market’s view of the
creditworthiness of JPMorgan Chase Financial Company LLC or
JPMorgan Chase & Co. • You are exposed to the risk of decline
in the level of each Index . • Your payment at maturity will be
determined by the Lesser Performing Index. • The benefit provided b
y the Barrier Amount may terminate on the Observation Date. • No
interest payments, dividend payments or voting rights. • The notes
are subject to the risks associated with non - U.S. securities. •
The notes do not provide direct exposure to fluctuations in foreign
exchange rates with respect to the EURO STOXX 50 ® Index. • The
notes are subject to currency exchange risk with respect to the
STOXX ® Europe 600 Index . • As a finance subsidiary, JPMorgan
Chase Financial Company LLC has no independent operations and has
limited assets. Selected Risks (continued) • The estimated value of
the notes will be lower than the original issue price (price to
public) of the notes. • The estimated value of the notes is
determined by reference to an internal funding rate. • The
estimated value of the notes does not represent future values and
may differ from others’ estimates. • The value of the notes, which
may be reflected in customer account statements, may be higher than
the then current estimated value of the notes for a limited time
period. • Lack of liquidity: J.P. Morgan Securities LLC (who we
refer to as JPMS ) intends to offer to purchase the notes in the
secondary market but is not required to do so. The price, if any,
at which JPMS will be willing to purchase notes from you in the
secondary market, if at all, may result in a significant loss of
your principal. • Potential conflicts: We and our affiliates play a
variety of roles in connection with the issuance of notes,
including acting as calculation agent and hedging our obligations
under the notes, and making the assumptions used to determine the
pricing of the notes and the estimated value of the notes when the
terms of the notes are set. It is possible that such hedging or
other trading activities of J.P. Morgan or its affiliates could
result in substantial returns for J.P. Morgan and its affiliates
while the value of the notes decline. • The tax consequences of the
notes may be uncertain. You should consult your tax adviser
regarding the U.S. federal income tax consequences of an investment
in the notes . . Additional Information SEC Legend: JPMorgan Chase
Financial Company LLC and JPMorgan Chase & Co. have filed a
registration statement (including a pr osp ectus) with the SEC for
any offerings to which these materials relate. Before you invest,
you should read the prospectus in that registration statement and
the other documents relating to this offering that JPM organ Chase
Financial Company LLC and JPMorgan Chase & Co. has filed with
the SEC for more complete information about JPMorgan Chase
Financial Company LLC and JPMorgan Chase & Co. and this
offering. You may get the se documents without cost by visiting
EDGAR on the SEC web site at www.sec.gov. Alternatively, JPMorgan
Chase Financial Company LLC and JPMorgan Chase & Co., any agent
or any dealer participating in the this offering will arrange to
send you the pr ospectus and each prospectus supplement as well as
any product supplement, underlying supplement and preliminary
pricing supplement if you so request by calling toll - free 1 - 866
- 535 - 9248. IRS Circular 230 Disclosure: JPMorgan Chase & Co.
and its affiliates do not provide tax advice. Accordingly, any
discussion o f U .S. tax matters contained herein (including any
attachments) is not intended or written to be used, and cannot be
used, in connection with the promotion, marketing or recommendation
by anyone unaffiliated with JPMorgan Cha se & Co. of any of the
matters addressed herein or for the purpose of avoiding U.S. tax -
related penalties. Investment suitability must be determined
individually for each investor, and the financial instruments
described herein may not be suitable for all investors. This
information is not intended to provide and should not be relied
upon as providing accounting, legal, regulatory or tax advice.
Investors should consult with their own advisers as to these
matters. This material is not a product of J.P. Morgan Research
Departments Free Writing Prospectus Filed Pursuant to Rule 433,
Registration Statement Nos. 333 - 236659 and 333 - 236659 - 01
North America Structured Investments 5 yr SX5E / SXXP Uncapped
Accelerated Barrier Notes The risks identified above are not
exhaustive. Please see “Risk Factors” in the prospectus supplement
and the applicable product supplement and underlying supplement and
“Selected Risk Considerations” in the applicable preliminary
pricing supplement for additional information
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From May 2022 to Jun 2022
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Jun 2021 to Jun 2022